Ausgabe 1/2012
Inhalt (22 Artikel)
Which patients do I treat? An experimental study with economists and physicians
Marlies Ahlert, Stefan Felder, Bodo Vogt
A cost-benefit analysis on the specialization in departments of obstetrics and gynecology in Japan
Junyi Shen, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Tadashi Kimura, Kenichiro Morishige, Tatsuyoshi Saijo
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Jose Martinez-Raga, Francisco Gonzalez-Saiz, Julian Oñate, Itziar Oyagüez, Eliazar Sabater, Miguel A Casado
Community-based health insurance and social capital: a review
Hermann Pierre Pythagore Donfouet, Pierre-Alexandre Mahieu
Organizational boundaries of medical practice: the case of physician ownership of ancillary services
John E Schneider, Robert L Ohsfeldt, Cara M Scheibling, Sarah A Jeffers
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Antonio J García-Ruiz, Lucía Pérez-Costillas, Ana C Montesinos, Javier Alcalde, Itziar Oyagüez, Miguel A Casado
The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective
Jan Zeidler, Lara Slawik, Jochen Fleischmann, Wolfgang Greiner
Economic burden of osteoporotic fractures in Austria
Hans Peter Dimai, Kurt Redlich, Monika Peretz, Fredrik Borgström, Uwe Siebert, Jörg Mahlich
Health and vulnerability to poverty in Ghana: evidence from the Ghana Living Standards Survey Round 5
Jacob Novignon, Justice Nonvignon, Richard Mussa, Levison S Chiwaula
A modified Kakwani measure for health inequality
Mototsugu Fukushige, Noriko Ishikawa, Satoko Maekawa
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
Alexander Kuhlmann, Ulrike Theidel, Mathias W Pletz, J-Matthias Graf von der Schulenburg
Wealth and antenatal care use: implications for maternal health care utilisation in Ghana
Eric Arthur
Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs
Francesc Homar, Virginia Lozano, Juan Martínez-Gómez, Itziar Oyagüez, Antonio Pareja, Antoni Payeras, Joaquín Serrano, Carmen Carratalá, Miguel Ángel Casado
Estimating cost-effectiveness in public health: a summary of modelling and valuation methods
Kevin Marsh, Ceri J Phillips, Richard Fordham, Evelina Bertranou, Janine Hale
Reporting heterogeneity in self-assessed health among elderly Europeans
Christian Pfarr, Andreas Schmid, Udo Schneider
Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany
Matthias Vogl
The national health insurance scheme: perceptions and experiences of health care providers and clients in two districts of Ghana
Philip Ayizem Dalinjong, Alexander Suuk Laar
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Jan Zeidler, Thomas Mittendorf, Rüdiger Müller, Johannes von Kempis
The effects of public and private health care expenditure on health status in sub-Saharan Africa: new evidence from panel data analysis
Jacob Novignon, Solomon A Olakojo, Justice Nonvignon
Methodological considerations in cost of illness studies on Alzheimer disease
Nagede Costa, Helene Derumeaux, Thomas Rapp, Valérie Garnault, Laura Ferlicoq, Sophie Gillette, Sandrine Andrieu, Bruno Vellas, Michel Lamure, Alain Grand, Laurent Molinier
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Deniz Schobert, Vanessa Remy, Oliver Schoeffski